Get the Stockscreener App
17.05
2.59%
0.43
After Hours:
16.06
-0.99
-5.81%
Si Bone Inc stock is traded at $17.05, with a volume of 616.71K.
It is up +2.59% in the last 24 hours and down -1.62% over the past month.
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
See More
Previous Close:
$16.62
Open:
$16.91
24h Volume:
616.71K
Relative Volume:
0.96
Market Cap:
$756.16M
Revenue:
$206.22M
Net Income/Loss:
$-16.70M
P/E Ratio:
-44.17
EPS:
-0.386
Net Cash Flow:
$-5.55M
1W Performance:
-0.41%
1M Performance:
-1.62%
6M Performance:
+0.12%
1Y Performance:
-1.16%
1-Day Range:
$16.73
$17.26
1-Week Range:
$16.26
$17.33
52-Week Range:
$11.48
$21.89
Si Bone Inc Stock (SIBN) Company Profile
Name
Si Bone Inc
Sector
Industry
Phone
(408) 207-0700
Address
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
Compare SIBN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SIBN
Si Bone Inc
|
17.05 | 737.09M | 206.22M | -16.70M | -5.55M | -0.386 |
ABT
Abbott Laboratories
|
104.49 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
336.74 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
84.22 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
45.51 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.04 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Initiated | TD Cowen | Buy |
| Aug-06-24 | Reiterated | Needham | Buy |
| Mar-28-24 | Initiated | Piper Sandler | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Apr-07-22 | Resumed | Cantor Fitzgerald | Overweight |
| Jun-08-21 | Initiated | Citigroup | Buy |
| Mar-09-21 | Reiterated | Needham | Buy |
| Dec-16-20 | Reiterated | Needham | Buy |
| Aug-04-20 | Reiterated | Needham | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-05-20 | Reiterated | Needham | Buy |
| Feb-19-20 | Initiated | Needham | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Dec-18-19 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-12-18 | Initiated | BofA/Merrill | Buy |
| Nov-12-18 | Initiated | Canaccord Genuity | Buy |
| Nov-12-18 | Initiated | JMP Securities | Mkt Outperform |
| Nov-12-18 | Initiated | Morgan Stanley | Overweight |
View All
Si Bone Inc Stock (SIBN) Latest News
SI-BONE Inc (SIBN) Balance Sheet - TradingKey
SI-BONE Inc (SIBN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
SI-BONE Inc (SIBN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SI-BONE Inc (SIBN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
SI-BONE, Inc. Revenue Breakdown – FWB:2K3 - TradingView
SI-BONE, Inc. Revenue Breakdown – GETTEX:2K3 - TradingView
SI-BONE Inc (SIBN) Valuation: PE, PB & Fair Value Analysis - TradingKey
SI-BONE Inc (SIBN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
SI-BONE Inc (SIBN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
SI-BONE to report Q2 2026 results, host conference call - Bitget
Understanding the Setup: (SIBN) and Scalable Risk - Stock Traders Daily
SI-BONE to report second quarter 2026 results on August 3 - scanx.trade
SI-BONE schedules a 4:30 p.m. ET webcast for Aug. 3 - Stock Titan
SIBN Maintained by Truist Securities -- Price Target Raised to $21 - GuruFocus
Truist Financial Maintains Si-Bone(SIBN.US) With Buy Rating, Raises Target Price to $21 - Moomoo
Truist Securities Adjusts Price Target on SI-BONE to $21 From $18, Maintains Buy Rating - marketscreener.com
ViCentra appoints CFO and board member ahead of U.S. expansion - Investing.com UK
ViCentra appoints CFO and board member ahead of U.S. expansion By Investing.com - Investing.com Nigeria
SI-BONE Q1 2026 Earnings: EPS Surges Past Estimates Despite Revenue UncertaintyTrough Earnings Signal - dars.gov.et
Si-Bone SVP Michael Pisetsky sells $52,375 in stock - Investing.com
Si-Bone CFO Anshul Maheshwari sells $55,626 in company stock - Investing.com
Form 4 Si-Bone Inc For: 6 July By Investing.com - Investing.com Nigeria
Si-Bone CFO Anshul Maheshwari sells $55,626 in company stock By Investing.com - Investing.com South Africa
Si-Bone SVP Michael Pisetsky sells $52,375 in stock By Investing.com - Investing.com South Africa
SI-BONE (SIBN) legal officer sells 3,134 shares in RSU tax sell-to-cover - Stock Titan
Si-Bone | 4: Statement of changes in beneficial ownership of securities-Officer PISETSKY MICHAEL A. - Moomoo
SI-BONE (NASDAQ: SIBN) CFO sells shares to cover RSU tax withholding - Stock Titan
Si-Bone Company Profile & Introduction - Moomoo
SIBNSI-BONE Inc Latest SEC Filings - Finviz
Price to book forward of SI-BONE, Inc. – NASDAQ:SIBN - TradingView
Price to sales forward of SI-BONE, Inc. – NASDAQ:SIBN - TradingView
Price to earnings forward of SI-BONE, Inc. – NASDAQ:SIBN - TradingView
SI-BONE Inc. (SIBN) Q1 2026 Earnings: EPS Beats Estimates Significantly Amid Operational ProgressCapex Guidance - dars.gov.et
SIBN Q1 2026 Earnings: EPS Surprises to the Upside with 48% BeatAnalyst Drop Coverage - dars.gov.et
SI-BONE, Inc. Actuals & Estimates (NASDAQ:SIBN) - TradingView
SI-BONE Inc. (SIBN) Attempts to Reclaim Ground After Recent PullbackFactor Crowding - dars.gov.et
SI-BONE Inc. (SIBN) Q1 2026 Earnings: EPS Surprise Drives Positive Market ReactionSegment Revenue Breakdown - dars.gov.et
SI-BONE outlines path to profitability, shares trade on Nasdaq in a volatile medtech sector - AD HOC NEWS
SI-BONE strategy focuses on differentiated sacropelvic implants, shares on Nasdaq in a competitive m - AD HOC NEWS
SIBN Technical Analysis & Stock Price Forecast - Intellectia AI
SI-BONE Inc. (SIBN) Rallies 3.68% as Shares Approach Key Resistance LevelRatio Spread Trade - dars.gov.et
SI-BONE Inc (SIBN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
SI-BONE Inc (SIBN) Institutional Confidence - TradingKey
SI-BONE Inc (SIBN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Precision Trading with Si-bone Inc. (SIBN) Risk Zones - Stock Traders Daily
SI-BONE Inc. (SIBN) Q1 2026 Earnings: Narrowed Loss Beats Street Estimates by Wide MarginROA Comparison - dars.gov.et
SIBN: Multi-product innovation, expanded partnerships, and reimbursement tailwinds set up multi-year growth - TradingView
SI-BONE Inc. (SIBN) Gains 1.85% as Stock Tests Key Resistance LevelAI Trade Signals - newsline.com
SIBN Q1 2026 Earnings: Earnings Beat Driven by Strong Operational ExecutionNew Analyst Coverage - newsline.com
SI-BONE Inc. (SIBN) Q1 2026 Earnings: EPS Beat Drives Shares HigherBook Value Growth - newsline.com
Director at SI-BONE (SIBN) granted 10,957 restricted stock units - Stock Titan
Si Bone Inc Stock (SIBN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
4.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):